Cargando…

COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

Improving early diagnosis along with timely and effective treatment of COVID-19 are urgently needed. However, at present, the mechanisms underlying disease spread and development, defined prognosis, and immune status of patients with COVID-19 remain to be determined. Patients with severe disease sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macciò, Antonio, Oppi, Sara, Madeddu, Clelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868172/ https://www.ncbi.nlm.nih.gov/pubmed/33550983 http://dx.doi.org/10.1186/s13048-021-00772-6

Ejemplares similares

Defibrotide Has a Role in COVID-19 Therapy
por: Macciò, Antonio, et al.
Publicado: (2022)

The COVID-19 Cytokine Storm; What We Know So Far
por: Ragab, Dina, et al.
Publicado: (2020)

Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease
por: Maccio, Antonio, et al.
Publicado: (2021)

Experimental Drugs for Chemotherapy- and Cancer-Related Anemia
por: Madeddu, Clelia, et al.
Publicado: (2021)

Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer
por: Sanna, Elisabetta, et al.
Publicado: (2021)

Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report
por: Madeddu, Clelia, et al.
Publicado: (2022)

Diagnostic Framework of Pelvic Massive Necrosis with Peritonitis following Chemoradiation for Locally Advanced Cervical Cancer: When Is the Surgery Not Demandable? A Case Report and Literature Review
por: Sanna, Elisabetta, et al.
Publicado: (2022)

Q&A: What do we know about influenza and what can we do about it?
por: Doherty, Peter C, et al.
Publicado: (2009)

Ketamine plus Alcohol: What We Know and What We Can Expect about This
por: Kobayashi, Natalia Harumi Correa, et al.
Publicado: (2022)

Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients
por: Macciò, Antonio, et al.
Publicado: (2009)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Correspondence on “Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer” by Polen-De et al
por: Maccio, Antonio, et al.
Publicado: (2022)

Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature
por: Macciò, Antonio, et al.
Publicado: (2021)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

What We Know and Don't Know About Lyme Disease
por: Donta, Sam T.
Publicado: (2022)

What do we know about neutrinos?
por: Vannucci, François
Publicado: (1994)

Bacteria and What We Know about Them
por: Fort, J. M.
Publicado: (1905)

What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021)

What We Know and Do Not Know about Sex and Cardiac Disease
por: Konhilas, John P.
Publicado: (2010)

Neuropathic pain; what we know and what we should do about it
por: Smith, Peter A.
Publicado: (2023)

What do we know about perioperative hypersensitivity reactions and what can we do to improve perioperative safety?
por: Kosciuczuk, Urszula, et al.
Publicado: (2021)

THE PHYSICAL AND MENTAL HEALTH OF HOME HEALTHCARE WORKERS: WHAT DO WE KNOW AND WHAT CAN WE DO ABOUT IT?
por: Sterling, Madeline
Publicado: (2022)

What Do We Know about Suicide Bereavement, and What We Can Do to Help Suicide-Loss Survivors?
por: Levi-Belz, Yossi, et al.
Publicado: (2023)

Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn
por: Augusto, Ronaldo de Carvalho, et al.
Publicado: (2018)

What We Know and What We Need to Know about Aromatic and Cationic Biogenic Amines in the Gastrointestinal Tract
por: Fernández-Reina, Alberto, et al.
Publicado: (2018)

Enhancer RNA: What we know and what we can achieve
por: Han, Zhenzhen, et al.
Publicado: (2022)

What we know about mathematics teaching and learning
por: McREL
Publicado: (2010)

RESCO? Now we know what is it all about!
Publicado: (1980)

What do we know about the Higgs boson ?
por: Gambino, Paulo
Publicado: (2002)

What we still don't know about AIDS
por: Robertson, Miranda
Publicado: (2009)

The disordered mind: what we know about schizophrenia
por: O'Brien, P T
Publicado: (1978)

What do We Know about Neonatal Cognition?
por: Streri, Arlette, et al.
Publicado: (2013)

What We Know Currently about Mirror Neurons
por: Kilner, J.M., et al.
Publicado: (2013)

What we know about ocular manifestations of Ebola
por: Moshirfar, Majid, et al.
Publicado: (2014)

What Do We Know about Opioids and the Kidney?
por: Mallappallil, Mary, et al.
Publicado: (2017)

What We Know About Tuberculosis Transmission: An Overview
por: Churchyard, Gavin, et al.
Publicado: (2017)

What do we know about Tietze’s syndrome?
por: Rokicki, Wojciech, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nuvhcn45on91lbqne7804mdaco